M. Janssens

发表

First-in-Human Randomized Study to Assess the Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus (RSV) Vaccine Based on Chimpanzee-Adenovirus-155 Viral Vector–Expressing RSV Fusion, Nucleocapsid, and Antitermination Viral Proteins in Healthy Adults

P. Klenerman, A. Leach, P. Cicconi, 2019, Clinical Infectious Diseases.

A Randomized, Controlled Dose-Finding Phase II Study of the M72/AS01 Candidate Tuberculosis Vaccine in Healthy PPD-Positive Adults

M. Demoitié, S. Gatchalian, Joe D. Cohen, 2013, Journal of Clinical Immunology.

Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans

R. A. van den Berg, A. Callegaro, A. Marchant, 2017, Front. Immunol..

Safety and immunogenicity of three doses of non-typeable Haemophilus influenzae-Moraxella catarrhalis (NTHi-Mcat) vaccine when administered according to two different schedules: a phase 2, randomised, observer-blind study

G. Di Maro, M. Janssens, T. Schwarz, 2022, Respiratory Research.

Immunogenicity and Safety of a Booster Dose of an Investigational Adjuvanted Polyprotein HIV-1 Vaccine in Healthy Adults and Effect of Administration of Chloroquine

G. Leroux-Roels, M. Janssens, Laurence Fissette, 2014, Clinical and Vaccine Immunology.

Circumsporozoite-Specific T Cell Responses in Children Vaccinated with RTS,S/AS01E and Protection against P falciparum Clinical Malaria

K. Marsh, A. Olotu, P. Bejon, 2011, PloS one.

Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants

P. van Damme, U. D'Oro, O. Finco, 2021, NPJ vaccines.

Induction of Plasmodium falciparum-Specific CD4+ T Cells and Memory B Cells in Gabonese Children Vaccinated with RTS,S/AS01E and RTS,S/AS02D

M. Demoitié, S. Agnandji, B. Lell, 2011, PloS one.

Protective Immunity Induced with the RTS,S/AS Vaccine Is Associated with IL-2 and TNF-α Producing Effector and Central Memory CD4+ T Cells

Joe D. Cohen, O. Ofori-Anyinam, P. Moris, 2011, PloS one.

Safety and immunogenicity of an adjuvanted protein therapeutic HIV-1 vaccine in subjects with HIV-1 infection: a randomised placebo-controlled study.

T. Harrer, J. van Lunzen, G. Fätkenheuer, 2014, Vaccine.

Processing of blood samples influences PBMC viability and outcome of cell-mediated immune responses in antiretroviral therapy-naïve HIV-1-infected patients.

G. Leroux-Roels, L. Vandekerckhove, P. Moris, 2014, Journal of immunological methods.

Harmonization and qualification of intracellular cytokine staining to measure influenza-specific CD4+ T cell immunity within the FLUCOP consortium

R. Cox, G. Leroux-Roels, E. Gianchecchi, 2022, Frontiers in Immunology.

Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.

G. Leroux-Roels, E. Hanon, P. Moris, 2008, Vaccine.

Modulation of CD3-gamma gene expression after HIV type 1 infection of the WE17/10 T cell line is progressive and occurs in concert with decreased production of viral p24 antigen.

R. Kettmann, K. Willard-Gallo, L. Willems, 1996, AIDS research and human retroviruses.

Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems.

M. Altfeld, G. Leroux-Roels, M. Janssens, 2010, Vaccine.

Safety, immunogenicity and immediate pain of intramuscular versus subcutaneous administration of a measles–mumps–rubella–varicella vaccine to children aged 11–21 months

R. Schmidt-Ott, M. Knuf, M. Janssens, 2010, European Journal of Pediatrics.

Human Immunodeficiency Virus Type 2 Produces a Defect in CD3-γ Gene Transcripts Similar to That Observed for Human Immunodeficiency Virus Type 1

R. Kettmann, K. Willard-Gallo, I. Segura, 1999, Journal of Virology.

Human Immunodeficiency Virus Type 1 Transcripts Similar to That Observed for Gene γ Produces a Defect in CD 3-Human Immunodeficiency Virus Type 2

R. Kettmann, K. Willard-Gallo, I. Segura, 1998 .

Impact of adjuvants on CD4(+) T cell and B cell responses to a protein antigen vaccine: Results from a phase II, randomized, multicenter trial.

I. Carletti, P. van Damme, P. Kremsner, 2016, Clinical immunology.

Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination.

I. Carletti, G. Leroux-Roels, M. Janssens, 2015, Vaccine.

Induction of Strong HIV-1–Specific CD4+ T-Cell Responses Using an HIV-1 gp120/NefTat Vaccine Adjuvanted With AS02A in Antiretroviral-Treated HIV-1–Infected Individuals

M. Altfeld, M. Demoitié, T. Flynn, 2012, Journal of acquired immune deficiency syndromes.

An Adjuvanted Polyprotein HIV-1 Vaccine Induces Polyfunctional Cross-Reactive CD4+ T Cell Responses in Seronegative Volunteers

I. Carletti, M. Demoitié, G. Leroux-Roels, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of adjuvants on CD 4 + T cell and B cell responses to a protein antigen vaccine : Results from a phase II , randomized , multicenter trial

I. Carletti, P. Kremsner, A. Marchant, 2016 .

T Cell Responses to the RTS,S/AS01E and RTS,S/AS02D Malaria Candidate Vaccines Administered According to Different Schedules to Ghanaian Children

Kwaku Poku Asante, S. Owusu-Agyei, D. Dosoo, 2011, PloS one.

Persistence of vaccine-elicited immune response up to 14 years post-HIV gp120-NefTat/AS01B vaccination.

E. Jongert, M. Debois, G. Tomaras, 2020, Vaccine.

A Randomized, Controlled Dose-Finding Phase II Study of the M72/AS01 Candidate Tuberculosis Vaccine in Healthy PPD-Positive Adults

M. Demoitié, S. Gatchalian, Joe D. Cohen, 2013, Journal of Clinical Immunology.

Whole blood can be used as an alternative to isolated peripheral blood mononuclear cells to measure in vitro specific T-cell responses in human samples.

E. Jongert, O. Ofori-Anyinam, P. Moris, 2021, Journal of immunological methods.

Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems.

M. Altfeld, G. Leroux-Roels, M. Janssens, 2010, Vaccine.

Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine

P. Hillemanns, P. Durando, M. Dionne, 2019, The Journal of infectious diseases.